Sfoglia per Titolo
Pharmacodynamic targets of psychotic patients treated with a long-acting therapy
2017-01-01 Ventriglio, A; Petito, A; Gentile, A; Vitrani, G; Bonfitto, I; Cecere, Ac; Rinaldi, A; Dimatteo, C; D'Andrea, G; Margaglione, M; Bellomo, A.
Pharmacodynamic targets of psychotic patients treated with a long-acting therapy
2017-01-01 Ventriglio, A; Petito, A; Gentile, A; Vitrani, G; Bonfitto, I; Cecere, Ac; Rinaldi, A; Dimatteo, C; D'Andrea, G; Maurizio, M; Bellomo, A
[Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
1988-01-01 V., Procacci; A., Giovine; M. G., Roberto; N. D., Reda; G., Lasorsa; Vendemiale, Gianluigi; N., Stufano; E., Altomare
[Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
1988-01-01 V., Procacci; A., Giovine; M. G., Roberto; A. M., Ronchi; G., Lasorsa; Vendemiale, Gianluigi; N., Stufano; E., Altomare
Pharmacoeconomics of synthetic therapies for multiple sclerosis
2019-01-01 D’Amico, E.; Chisari, C. G.; Gitto, L.; Zanghì, A.; Toscano, S.; Patti, F.
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes
2016-01-01 Panza, Francesco; Lozupone, Madia; Stella, Eleonora; Miscio, Giuseppe; La Montagna, Maddalena; Daniele, Antonio; di Mauro, Lazzaro; Bellomo, Antonello; Logroscino, Giancarlo; Greco, Antonio; Seripa, Davide
Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline
2019-01-01 Miscio, G.; Paroni, G.; Bisceglia, P.; Gravina, C.; Urbano, M.; Lozupone, M.; Piccininni, C.; Prisciandaro, M.; Ciavarella, G.; Daniele, A.; Bellomo, A.; Panza, F.; Di Mauro, L.; Greco, A.; Seripa, D.
Pharmacogenetics Of Cyp2d6 In The Revolving Door Condition Of Patients With Psychiatric Illnesses
2017-01-01 Miscio, G.; Lozupone, M.; Panza, F.; Stella, E.; La Montagna, M.; Gravina, C.; Urbano, M.; Bisceglia, P.; Daniele, A.; Bellomo, A.; Di Mauro, L.; Greco, A.; Seripa, D.
Pharmacogenetics of dabigatran etexilate interindividual variability
2016-01-01 Dimatteo, C; D'Andrea, G; Vecchione, G; Paoletti, O; Cappucci, F; Tiscia, Gl; Buono, M; Grandone, E; Testa, S; Margaglione, M.
Pharmacogenetics of dabigatran etexilate interindividual variability
2016-01-01 Dimatteo, Claudia; D'Andrea, Giovanna; Vecchione, Gennaro; Paoletti, Oriana; Cappucci, Filomena; Tiscia, Giovanni Luca; Buono, Matteo; Grandone, Elvira; Testa, Sophie; Margaglione, Maurizio
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
2017-01-01 Lozupone, M; Panza, F; Stella, E; La Montagna, M; Bisceglia, P; Miscio, G; Galizia, I; Daniele, A; di Mauro, L; Bellomo, Antonello; Logroscino, G; Greco, A; Seripa, D.
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.
2018-01-01 Prudente, S; Di Paola, R; Pezzilli, S; Garofolo, M; Lamacchia, O; Filardi, T; Mannino, Gc; Mercuri, L; Alberico, F; Scarale, Mg; Sesti, G; Morano, S; Penno, G; Cignarelli, M; Copetti, M; Trischitta, V.
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation
2015-01-01 Caletti, Chiara; Granata, Simona; Tomei, Paola; DALLA GASSA, Alessandra; Lupo, Antonio; Zaza, Gianluigi
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients
2010-01-01 Zaza, Gianluigi; Granata, Simona; Sallustio, F; Grandaliano, G; Schena, Fp
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.
2010-01-01 Zaza, G; Granata, S; Sallustio, F; Grandaliano, Giuseppe; Schena, F. P.
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis
2018-01-01 Patti, Francesco; Chisari, Clara G; D’Amico, Emanuele; Zappia, Mario
Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes
2015-01-01 Monitillo, F; Iacoviello, M; Caldarola, P; Valle, R; Chiatto, M; Aspromonte, N
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma
2016-01-01 Farolfi, A.; Schepisi, G.; Conteduca, V.; Burgio, S. L.; Lolli, C.; De Giorgi, U.
[Pharmacologic induction of fetal immobilization for prenatal diagnostic-therapeutic procedures].
1995-01-01 Greco, Pantaleo; Dardes, N; Fiore, G; Vimercati, A; Sasanelli, B; Loverro, G; Resta, M; Spagnolo, P.
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health
2021-01-01 Bukke, V. N.; Archana, M.; Villani, R.; Serviddio, G.; Cassano, T.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Pharmacodynamic targets of psychotic patients treated with a long-acting therapy | 1-gen-2017 | Ventriglio, A; Petito, A; Gentile, A; Vitrani, G; Bonfitto, I; Cecere, Ac; Rinaldi, A; Dimatteo, C; D'Andrea, G; Margaglione, M; Bellomo, A. | |
Pharmacodynamic targets of psychotic patients treated with a long-acting therapy | 1-gen-2017 | Ventriglio, A; Petito, A; Gentile, A; Vitrani, G; Bonfitto, I; Cecere, Ac; Rinaldi, A; Dimatteo, C; D'Andrea, G; Maurizio, M; Bellomo, A | |
[Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus]. | 1-gen-1988 | V., Procacci; A., Giovine; M. G., Roberto; N. D., Reda; G., Lasorsa; Vendemiale, Gianluigi; N., Stufano; E., Altomare | |
[Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics]. | 1-gen-1988 | V., Procacci; A., Giovine; M. G., Roberto; A. M., Ronchi; G., Lasorsa; Vendemiale, Gianluigi; N., Stufano; E., Altomare | |
Pharmacoeconomics of synthetic therapies for multiple sclerosis | 1-gen-2019 | D’Amico, E.; Chisari, C. G.; Gitto, L.; Zanghì, A.; Toscano, S.; Patti, F. | |
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes | 1-gen-2016 | Panza, Francesco; Lozupone, Madia; Stella, Eleonora; Miscio, Giuseppe; La Montagna, Maddalena; Daniele, Antonio; di Mauro, Lazzaro; Bellomo, Antonello; Logroscino, Giancarlo; Greco, Antonio; Seripa, Davide | |
Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline | 1-gen-2019 | Miscio, G.; Paroni, G.; Bisceglia, P.; Gravina, C.; Urbano, M.; Lozupone, M.; Piccininni, C.; Prisciandaro, M.; Ciavarella, G.; Daniele, A.; Bellomo, A.; Panza, F.; Di Mauro, L.; Greco, A.; Seripa, D. | |
Pharmacogenetics Of Cyp2d6 In The Revolving Door Condition Of Patients With Psychiatric Illnesses | 1-gen-2017 | Miscio, G.; Lozupone, M.; Panza, F.; Stella, E.; La Montagna, M.; Gravina, C.; Urbano, M.; Bisceglia, P.; Daniele, A.; Bellomo, A.; Di Mauro, L.; Greco, A.; Seripa, D. | |
Pharmacogenetics of dabigatran etexilate interindividual variability | 1-gen-2016 | Dimatteo, C; D'Andrea, G; Vecchione, G; Paoletti, O; Cappucci, F; Tiscia, Gl; Buono, M; Grandone, E; Testa, S; Margaglione, M. | |
Pharmacogenetics of dabigatran etexilate interindividual variability | 1-gen-2016 | Dimatteo, Claudia; D'Andrea, Giovanna; Vecchione, Gennaro; Paoletti, Oriana; Cappucci, Filomena; Tiscia, Giovanni Luca; Buono, Matteo; Grandone, Elvira; Testa, Sophie; Margaglione, Maurizio | |
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come? | 1-gen-2017 | Lozupone, M; Panza, F; Stella, E; La Montagna, M; Bisceglia, P; Miscio, G; Galizia, I; Daniele, A; di Mauro, L; Bellomo, Antonello; Logroscino, G; Greco, A; Seripa, D. | |
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus. | 1-gen-2018 | Prudente, S; Di Paola, R; Pezzilli, S; Garofolo, M; Lamacchia, O; Filardi, T; Mannino, Gc; Mercuri, L; Alberico, F; Scarale, Mg; Sesti, G; Morano, S; Penno, G; Cignarelli, M; Copetti, M; Trischitta, V. | |
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation | 1-gen-2015 | Caletti, Chiara; Granata, Simona; Tomei, Paola; DALLA GASSA, Alessandra; Lupo, Antonio; Zaza, Gianluigi | |
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients | 1-gen-2010 | Zaza, Gianluigi; Granata, Simona; Sallustio, F; Grandaliano, G; Schena, Fp | |
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. | 1-gen-2010 | Zaza, G; Granata, S; Sallustio, F; Grandaliano, Giuseppe; Schena, F. P. | |
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis | 1-gen-2018 | Patti, Francesco; Chisari, Clara G; D’Amico, Emanuele; Zappia, Mario | |
Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes | 1-gen-2015 | Monitillo, F; Iacoviello, M; Caldarola, P; Valle, R; Chiatto, M; Aspromonte, N | |
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma | 1-gen-2016 | Farolfi, A.; Schepisi, G.; Conteduca, V.; Burgio, S. L.; Lolli, C.; De Giorgi, U. | |
[Pharmacologic induction of fetal immobilization for prenatal diagnostic-therapeutic procedures]. | 1-gen-1995 | Greco, Pantaleo; Dardes, N; Fiore, G; Vimercati, A; Sasanelli, B; Loverro, G; Resta, M; Spagnolo, P. | |
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health | 1-gen-2021 | Bukke, V. N.; Archana, M.; Villani, R.; Serviddio, G.; Cassano, T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile